IL-1 in Abdominal Aortic Aneurysms

J Cell Immunol. 2023;5(2):22-31. doi: 10.33696/immunology.5.163.ABSTRACTAbdominal Aortic Aneurysms (AAA) remain a clinically devastating disease with no effective medical treatment therapy. AAAs are characterized by immune cell infiltration, smooth muscle cell apoptosis, and extracellular matrix degradation. Interleukin-1 (IL-1) has been shown to play role in AAA associated inflammation through immune cell recruitment and activation, endothelial dysfunction, production of reactive oxygen species (ROS), and regulation of transcription factors of additional inflammatory mediators. In this review, we will discuss the principles of IL-1 signaling, its role in AAA specific inflammation, and regulators of IL-1 signaling. Additionally, we will discuss the influence of genetic and pharmacological inhibitors of IL-1 on experimental AAAs. Evidence suggests that IL-1 may prove to be a potential therapeutic target in the management of AAA disease.PMID:37476160 | PMC:PMC10357974 | DOI:10.33696/immunology.5.163
Source: Cellular Immunology - Category: Allergy & Immunology Authors: Source Type: research